| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1572-0241.2000.01846.X |
| P698 | PubMed publication ID | 10710057 |
| P2093 | author name string | Gleim GW | |
| Korelitz BI | |||
| Baiocco PJ | |||
| Zlatanic J | |||
| Rajapakse RO | |||
| P2860 | cites work | Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease | Q39515939 |
| The genetic toxicology of 6-mercaptopurine | Q40485200 | ||
| Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. | Q51044192 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| mercaptopurine | Q418529 | ||
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 684-688 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease | |
| P478 | volume | 95 |
| Q92437854 | A new insight of structures, bonding and electronic properties for 6-mercaptopurine and Ag8 clusters configurations: a theoretical perspective |
| Q28218219 | Anti-inflammatory and immunosuppressive drugs and reproduction |
| Q35044577 | Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety |
| Q34073437 | Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits? |
| Q33378151 | Azathioprine. Safety profile in multiple sclerosis patients |
| Q35918362 | Celiac disease and inflammatory bowel disease in pregnancy |
| Q34086102 | Comparative tolerability of treatments for inflammatory bowel disease |
| Q22242050 | European evidence based consensus on the diagnosis and management of Crohn's disease: special situations |
| Q36871960 | Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease |
| Q35760599 | Fertility and pregnancy in the patient with inflammatory bowel disease |
| Q36073770 | IBD and Pregnancy |
| Q46236864 | Immunosuppressants and Male Reproduction |
| Q28079553 | Infertility in men with inflammatory bowel disease |
| Q74256128 | Inflammatory Bowel Disease During Pregnancy |
| Q34268175 | Inflammatory bowel disease and pregnancy |
| Q73389030 | Inflammatory bowel disease during pregnancy |
| Q73122636 | Inflammatory bowel disease in pregnancy |
| Q78781468 | Inflammatory bowel disease in pregnancy |
| Q28388274 | Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review |
| Q46478936 | Infliximab and semen quality in men with inflammatory bowel disease |
| Q92701443 | Insights into the treatment of inflammatory bowel disease in pregnancy |
| Q26865914 | Management of inflammatory bowel disease in pregnancy |
| Q47992724 | Paternal drug use: before and during pregnancy |
| Q47621577 | Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease |
| Q34389885 | Practical medical management of Crohn's disease. |
| Q34745688 | Pregnancy and nursing in inflammatory bowel disease |
| Q27004038 | Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective |
| Q44031473 | Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease |
| Q36155827 | Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation |
| Q38370759 | Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive |
| Q34421471 | Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine |
| Q37995572 | Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease |
| Q34124884 | Teratogen update: azathioprine and 6-mercaptopurine. |
| Q47391247 | The associations of thiopurines with male fertility and paternally exposed offspring: a systematic review and meta-analysis |
| Q36443655 | The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease |
| Q44800878 | The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception |
| Q34152778 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations |
| Q36467833 | Therapy insight: drugs for gastrointestinal disorders in pregnant women |
| Q37798819 | Thiopurine therapy in inflammatory bowel disease |
| Q36747429 | Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing |
| Q33748043 | Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy |
| Q39435409 | Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease |
| Q38601306 | Use of Immunomodulators and Biologics Before, During, and After Pregnancy |
| Q43528414 | WAGR syndrome in a baby--the result of 6-MP treatment in a father affected by Crohn's disease? |
| Q73531524 | What's good for the goose should be good for the gander--6-MP use in fathers with inflammatory bowel disease |
| Q78032463 | [Indications for azathioprine treatment in inflammatory bowel disease] |
| Q84597679 | [Pregnancy under immunosuppression] |
| Q81323133 | [Treatment of ulcerative colitis: special situations] |
Search more.